Rocket Pharmaceuticals
RCKT
RCKT
78 hedge funds and large institutions have $206M invested in Rocket Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 5 closing their positions.
Holders
78
Holders Change
+12
Holders Change %
+18.18%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
29
Reduced
16
Closed
5
Calls
$447K
Puts
$4.08M
Net Calls
-$3.63M
Net Calls Change
-$3.65M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$17.5M |
| 2 |
DCM
2
DAFNA Capital Management
Los Angeles,
California
|
$2.25M |
| 3 |
3
Millennium Management
New York
|
$3.39M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$8.9M |
| 5 |
GTC
5
Ghost Tree Capital
New York
|
$1.61M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MCM
76
Manchester Capital Management
Manchester,
Vermont
| $4K | 400 | – | – |
|
77
Barclays
London,
United Kingdom
| $1K | 110 | -226 | -67% |
|
|
TCIM
78
TIAA CREF Investment Management
New York
| $482 | 50,792 | – | – |
|
79
Citadel Advisors
Miami,
Florida
| – | – | -16,909 | Closed |
|
|
OAM
80
Oxford Asset Management
Oxford,
United Kingdom
| – | – | -15,898 | Closed |
|
|
SO
81
STRS Ohio
Columbus,
Ohio
| – | – | -5,800 | Closed |
|
82
Citigroup
New York
| – | – | -4,909 | Closed |
|
|
TRCT
83
Tower Research Capital (TRC)
New York
| – | – | -868 | Closed |
|
84
Credit Agricole
Montrouge Cedex,
France
| – | – | – | – |
|
|
ACM
85
Advent Capital Management
New York
| – | – | – | – |
|
86
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|